Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Notes Payables (2024 - 2025)

Historic Notes Payables for Mangoceuticals (MGRX) over the last 2 years, with Q3 2025 value amounting to $100000.0.

  • Mangoceuticals' Notes Payables changed N/A to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year change of. This contributed to the annual value of $150000.0 for FY2024, which is N/A changed from last year.
  • Mangoceuticals' Notes Payables amounted to $100000.0 in Q3 2025.
  • Mangoceuticals' 5-year Notes Payables high stood at $500000.0 for Q2 2025, and its period low was $87500.0 during Q1 2024.